Organization
Universität Münster
6 clinical trials
Clinical trial
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain TumorsStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Phase I/II Dose Escalation Trial of Radiodynamic Therapy (RDT) With 5-Aminolevulinic Acid in Patients With First Recurrence of GlioblastomaStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Phase III Study Comparing Trabectedin (T) Versus T Plus tTF-NGR to Entrap T Inside the Tumor in Patients With Metastatic and/or Refractory Soft Tissue Sarcoma (STS)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfaStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
Biomarker-guided Implementation of Angiotensin-II (AT-II) to Reduce the Occurrence of Kidney Damage After Cardiac SurgeryStatus: Completed, Estimated PCD: 2022-12-19
Clinical trial
A Randomized, Open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer After Radical ProstatectomyStatus: Active (not recruiting), Estimated PCD: 2028-11-30